TGFB1 and gastric cancer: Astragaloside inhibits the conversion of E-cadherin to N-cadherin induced by TGF-β1 by inhibiting the PI3K/Akt/NF-κB pathway to inhibit the survival, invasion and metastasis of gastric cancer cells (Zhu and Wen, 2018).